Seeking men and women who are suffering COVID-19, but have not yet been hospitalized for a study of an investigational drug for mild to moderate COVID-19.
We are studying an investigational drug to reduce COVID-19 virus in people with mild to moderate COVID-19. Participants in this trial will receive either a placebo (looks like the drug, but doesn't contain active medicine) or one of up to four different strengths of the investigational drug.
What we're hoping for
Evaluate how safe an investigational drug is and how well it will work to help people with mild to moderate COVID-19.
ClinicalTrials.gov Identifier: NCT04427501